Skip to main content

Table 5 Adverse events during treatment with liposomal amphotericin B

From: Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia

Adverse events (AEs)

Frequency

Percentage

No AE

56

38.1 %

Raised transaminase

7

4.8 %

Hypokalemia

39

26.5 %

Infusion related reaction

16

10.9 %

Dyspepsia

7

4.8 %

Vomiting

8

5.4 %

Increased serum creatinine from the baseline

14

9.5 %